Skip to content
TrialScanner

NCT06056791

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Phase 1/Phase 2CompletedINMBLead

Registry record

Lead sponsor
Inmune Bio, Inc.
Conditions
Cancer; Metastatic Castration-resistant Prostate Cancer; mCRPC
Primary completion
Sep 10, 2025Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06056791 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.